Literature DB >> 15846528

Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors.

Ulrich Klotz.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15846528     DOI: 2005/11/smw-11057

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


× No keyword cloud information.
  3 in total

1.  The bridging function of clinical pharmacology.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-09       Impact factor: 2.953

2.  Clinical pharmacology in everyday clinical care.

Authors:  Petra A Thürmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

Review 3.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.